Would you recommend the following article to a politician, an athlete, a business executive, or a scientist?

Biovail Backs 2004 Earnings on Strong Sales Pharmaceutical firm Biovail Corp. on Tuesday narrowed the scope of its full-year revenue forecast to the middle of its prior estimate range, but backed its earnings prediction - excluding charges - of \$1.
